Bertolino Arthur Peter

EVP and Chief Medical Officer at Revance Therapeutics, Inc.

Sold, on record
$303k
Dollars the filings state
Form 4 sales
1
Latest Nov 17, 2015
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Revance Therapeutics, Inc.Plan not stated
    Nov 17 2015

    Sold 7,753 shares at $39.11 ($303k)

    Bertolino Arthur Peter, EVP and Chief Medical Officer

    Sold 18.6% of holdings ($1.6M position)34,001 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (1)

Form 144 notices and Form 4 sales by Bertolino Arthur Peter
Source
Nov 17, 2015Revance Therapeutics, Inc.EVP and Chief Medical OfficerForm 4 sale7,753$303k18.6%Plan not statedSEC